Deciphera, a subsidiary of Japan’s Ono Pharmaceutical, has received approval from the European Commission (EC) for Romvimza (vimseltinib) for the treatment of adult patients with symptomatic ...

Regeneron Pharmaceuticals has announced the primary endpoint was met in the Phase III OPTIMA trial investigating garetosmab ...

China’s Mabwell (688062.SH) and Californian biotech venture firm Aditum Bio have combined to launch Kalexo Bio.

The biologics supply chain has shifted from a technical backwater into a political and regulatory battleground. Vectors, ...

The European Commission (EC) has granted marketing authorization for US biotech major Biogen’s Zurzuvae (zuranolone) to treat ...

Danish pharma major Novo Nordisk (NOV: N) has reported positive Phase III data for its experimental oral version of Wegovy (semaglutide), showing weight-loss benefits close to those of the already ...

The European Court of Auditors has warned that Europe still lacks a reliable system to prevent and manage medicine shortages, ...

A life-sciences startup based in South San Francisco, focused on developing bispecific antibodies for immune and inflammatory diseases.

Spanish biotech ARTHEx has closed an expanded series B financing round totaling $87 million, led by French state-backed ...

South Korean biotech Alteogen (KOSDAQ:196170) has secured European Commission clearance for Eyluxvi (ALT-L9), its biosimilar ...

Belgian biopharma UCB has announced three-year data from the BE HEARD trials for Bimzelx (bimekizumab) in moderate to severe ...

Indian drugmakers are urging the government to ensure generic drugs are excluded from an ongoing US investigation, warning ...